Stockreport

Norgine welcomes positive CHMP opinion recommending approval of mavorixafor in the European Union for WHIM syndrome [Yahoo! Finance]

X4 Pharmaceuticals, Inc.  (XFOR) 
Last x4 pharmaceuticals, inc. earnings: 3/12 07:30 am Check Earnings Report
PDF decision expected from the European Commission in Q2 2026 Partnership with X4 Pharmaceuticals for Norgine-led commercialisation in Europe AMSTERDAM Feb. 27, 2026 /PRNe [Read more]